https://orcid.org/0000-0002-6173-3326
![A 50-year-old African man with well-controlled HIV infection presented with constitutional symptoms, progressive multiorgan failure, and raised inflammatory markers. He had a history of Kaposi sarcoma. An infective etiology was excluded. He had a rising white cell count and the blood film (panels A-B; May-Grünwald Giemsa stain; original magnification ×20 [A] and ×40 [B]) showed large cells with abundant, basophilic cytoplasm, irregular nuclei, and prominent nucleoli. / Immunophenotyping of the peripheral blood confirmed these cells to be λ-restricted plasma cells. Bone marrow biopsy demonstrated the same clonal plasma cells (panels C,E; May-Grünwald Giemsa stain, original magnification ×60 [C]; CD138 stain, original magnification ×20 [E]) and the presence of hemophagocytosis (panel D; May-Grünwald Giemsa stain; original magnification ×60). The main differential diagnoses were plasma cell myeloma or plasmablastic lymphoma, with the latter favored in the context of HIV infection. A positron emission tomography computed tomography scan showed mild splenomegaly but no lymphadenopathy or effusions. Subsequent results revealed a human herpesvirus 8 (HHV8) viremia of 70 million copies/mL, Kaposi sarcoma in the skin, and occasional HHV8+ cell in the trephine (panel F; HHV8 stain; original magnification ×40). Testing for Epstein-Barr virus was negative. The diagnosis was therefore revised to an HHV8-associated lymphoproliferative disorder, most likely multicentric Castleman disease. He was treated with 4 doses of rituximab and had a full clinical response. Castleman disease is known to involve the blood and bone marrow, but is only rarely seen without lymphadenopathy.](/view-large/figure/8031227/blood837823f1.jpeg)
A 50-year-old African man with well-controlled HIV infection presented with constitutional symptoms, progressive multiorgan failure, and raised inflammatory markers. He had a history of Kaposi sarcoma. An infective etiology was excluded. He had a rising white cell count and the blood film (panels A-B; May-Grünwald Giemsa stain; original magnification ×20 [A] and ×40 [B]) showed large cells with abundant, basophilic cytoplasm, irregular nuclei, and prominent nucleoli.
Immunophenotyping of the peripheral blood confirmed these cells to be λ-restricted plasma cells. Bone marrow biopsy demonstrated the same clonal plasma cells (panels C,E; May-Grünwald Giemsa stain, original magnification ×60 [C]; CD138 stain, original magnification ×20 [E]) and the presence of hemophagocytosis (panel D; May-Grünwald Giemsa stain; original magnification ×60). The main differential diagnoses were plasma cell myeloma or plasmablastic lymphoma, with the latter favored in the context of HIV infection. A positron emission tomography computed tomography scan showed mild splenomegaly but no lymphadenopathy or effusions. Subsequent results revealed a human herpesvirus 8 (HHV8) viremia of 70 million copies/mL, Kaposi sarcoma in the skin, and occasional HHV8+ cell in the trephine (panel F; HHV8 stain; original magnification ×40). Testing for Epstein-Barr virus was negative. The diagnosis was therefore revised to an HHV8-associated lymphoproliferative disorder, most likely multicentric Castleman disease. He was treated with 4 doses of rituximab and had a full clinical response. Castleman disease is known to involve the blood and bone marrow, but is only rarely seen without lymphadenopathy.
A 50-year-old African man with well-controlled HIV infection presented with constitutional symptoms, progressive multiorgan failure, and raised inflammatory markers. He had a history of Kaposi sarcoma. An infective etiology was excluded. He had a rising white cell count and the blood film (panels A-B; May-Grünwald Giemsa stain; original magnification ×20 [A] and ×40 [B]) showed large cells with abundant, basophilic cytoplasm, irregular nuclei, and prominent nucleoli.
Immunophenotyping of the peripheral blood confirmed these cells to be λ-restricted plasma cells. Bone marrow biopsy demonstrated the same clonal plasma cells (panels C,E; May-Grünwald Giemsa stain, original magnification ×60 [C]; CD138 stain, original magnification ×20 [E]) and the presence of hemophagocytosis (panel D; May-Grünwald Giemsa stain; original magnification ×60). The main differential diagnoses were plasma cell myeloma or plasmablastic lymphoma, with the latter favored in the context of HIV infection. A positron emission tomography computed tomography scan showed mild splenomegaly but no lymphadenopathy or effusions. Subsequent results revealed a human herpesvirus 8 (HHV8) viremia of 70 million copies/mL, Kaposi sarcoma in the skin, and occasional HHV8+ cell in the trephine (panel F; HHV8 stain; original magnification ×40). Testing for Epstein-Barr virus was negative. The diagnosis was therefore revised to an HHV8-associated lymphoproliferative disorder, most likely multicentric Castleman disease. He was treated with 4 doses of rituximab and had a full clinical response. Castleman disease is known to involve the blood and bone marrow, but is only rarely seen without lymphadenopathy.
For additional images, visit the ASH Image Bank, a reference and teaching tool that is continually updated with new atlas and case study images. For more information, visit http://imagebank.hematology.org.
